← Leaderboards
Matthew L Boisen
Corgenix Medical Corporation
$2,796,134
Attributed
$2,796,134
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2015–19$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$2,796,134 · 2
By mechanism
R44$2,000,000 · 1
R43$796,134 · 1
Top collaborators
No co-investigators on record.
Most similar at Corgenix Medical Corporation
Same institution · by research overlap
- Luis R. Lopez$590,176
- Kelly R Pitts$995,262
Others in their field
Top investigators on “Lassa Fever”
- Robert F Garry · Scripps Research Institute, The$51,855,254
- Alessandro Sette · La Jolla Institute For Immunology$22,115,370
- Matthias Schnell · Thomas Jefferson University$21,800,660
- Thomas William Geisbert · Boston University Medical Campus$20,808,527
- Sean M Amberg · Kineta, Inc.$18,993,187
- Pardis Christine Sabeti · Harvard University$18,428,342
Research focus
Lassa FeverNational Institute Of Allergy And Infectious DiseaseDiagnosticLaboratoriesMilitary PersonnelMedicalCommercializationDetectionEbola VirusImmunoassayAfricaAreaLassa VirusAssay DevelopmentCessation Of LifeBaseAntibodiesDesignAffinityDisease OutbreaksFeverGuidelinesAntigensPerformance
Grant awards (4)
Glycoprotein Immunoassay to Measure Protective Response to Lassa Vaccine$299,050
R43 · FY2019 · AI · contact PI
Glycoprotein Immunoassay to Measure Protective Response to Lassa Vaccine$497,084
R43 · FY2018 · AI · contact PI
Recombinant antigen diagnostics for filoviruses$1,000,000
R44 · FY2016 · AI · contact PI
Recombinant antigen diagnostics for filoviruses$1,000,000
R44 · FY2015 · AI · contact PI